Developments in Digital Wearable in Heart Failure and the Rationale for the Design of TRUE-HF (Ted Rogers Understanding of Exacerbations in Heart Failure) Apple CPET Study.

BACKGROUND

Heart failure (HF) is a highly prevalent condition characterized by exercise intolerance, an important metric for ambulatory prognostication. However, current methods to assess exercise capacity are often limited to tertiary HF centers, lacking scalability or accessibility. Wearable devices can enable near-continuous dynamic biometrics including exercise tolerance.

METHODS

Leveraging the capabilities of Apple Watch and a custom application, the TRUE-HF (Ted Rogers Understanding of Exacerbations in Heart Failure) Apple cardiopulmonary exercise testing study aims to investigate whether HealthKit data from Apple Watch can estimate cardiorespiratory fitness, as compared with the gold standard peak oxygen uptake from cardiopulmonary exercise testing. The TRUE-HF study will evaluate the potential impact of wearable technology in the functional assessment of ambulatory patients with HF. The primary end point is to use HealthKit variables to estimate a TRUE-HF peak oxygen uptake. We outline key features of this trial designed to reduce the burden of wearable technology. In addition, we highlight the benefits of various machine learning analyses, with a particular focus on transformer models for the wearable space.

CONCLUSIONS

Using cutting-edge wearable technology and machine learning analytics, TRUE-HF may provide state-of-the-art assessment of functional capacity by measuring participant-generated free-world data.

REGISTRATION

URL: https://www.clinicaltrials.gov; Unique identifier: NCT05008692.